[{"Assets_0_Q2_USD":"12278090000.0","CIK":"1593034","CommonStockSharesIssued_0_Q2_shares":"223284141.0","CommonStockSharesOutstanding_0_Q2_shares":"223284141.0","Country":"Ireland","EarningsPerShareBasic_1_Q2_USD":"-6.26","EarningsPerShareBasic_2_Q2_USD":"-7.04","EarningsPerShareDiluted_1_Q2_USD":"-6.26","EarningsPerShareDiluted_2_Q2_USD":"-7.04","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"340986000.0","NetIncomeLoss_1_Q2_USD":"-1396518000.0","NetIncomeLoss_2_Q2_USD":"-1570346000.0","OfficialName":"Endo International plc Ordinary Shares","ProfitLoss_1_Q2_USD":"-1396518000.0","ProfitLoss_2_Q2_USD":"-1570346000.0","RevenuesConverted_1_Q2_USD":"875731000.0","RevenuesConverted_2_Q2_USD":"1913331000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"809106000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"223158000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"223086000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"223158000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"223086000.0","filed":"20170808","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"ENDO INTERNATIONAL PLC","period":"20170630","qtrs":"0","uom":"USD"}]